Castle Biosciences
+$1.69 (+8.05%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CSTL and other ETFs, options, and stocks.
About CSTL
Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The firm offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis and recurrence for patients diagnosed with invasive cutaneous melanoma.
CEO
Derek J. Maetzold
Employees
345
Headquarters
Friendswood, Texas
Founded
2007
CSTL Key Statistics
Market cap
595.60M
Price-Earnings ratio
—
Dividend yield
—
Average volume
282.00K
High today
$22.72
Low today
$21.10
Open price
$21.12
Volume
253.47K
52 Week high
$78.92
52 Week low
$17.01
Analyst ratings
100%
of 7 ratings
Buy
100%
Hold
0%
Sell
0%
CSTL Earnings
-$0.97
-$0.65
-$0.32
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 8, After Hours